Inside JPMorgan’s new headquarters designed to lure back reluctant employees
In the face of employee backlash over JPMorgan Chase’s 5-day-a-week return to work mandate, company leaders are hoping their ...
BioPharma Dive21h
Amgen obesity drug on hold; Regeneron sets first dividend
The FDA has paused a study of Amgen’s early-stage candidate AMG 513. Elsewhere, Valneva got another approval and a radiopharma developer raised $112 million.
Regeneron Is Playing Defense With Capital Allocation
Regeneron's 2025 outlook includes defensive capital allocation, competitive pressure on Eylea, et cetera. Click here to read ...
dailymemphian5d
Regional One Health build could bring new life to Downtown ‘gateway’
Regional One Health’s new billion-dollar hospital could forge a new gateway to Downtown and help generate more business and residential activity.